Latest news
Innovent, Daiichi Sankyo Partner to Commercialise Vanflyta for FLT3-ITD Positive AML in China - BioPharma APACBioPharma APAC · Mon, 10 Aug 2026 18:33:43 GMTInnovent and Daiichi Sankyo sign deal for Vanflyta in China - Pharmaceutical Business review -Pharmaceutical Business review - · Mon, 10 Aug 2026 14:33:29 GMTM&A Roundup: Novo Nordisk Enters AI Drug Discovery Partnership with Amazon, Innate Pharma Partners with Sobi, Innovent Enters Commercialization Agreement with Daiichi Sankyo - Pharmaceutical ExecutivePharmaceutical Executive · Mon, 10 Aug 2026 13:57:46 GMTInnovent Adds Vanflyta to China Oncology Portfolio - Contract PharmaContract Pharma · Mon, 10 Aug 2026 12:39:04 GMTList of 39 Acquisitions by Lilly (Aug 2026) - TracxnTracxn · Mon, 03 Aug 2026 03:26:49 GMT